UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049282
Receipt No. R000056120
Scientific Title Effects of urinary independence support for stroke patients by a urination care team
Date of disclosure of the study information 2022/10/24
Last modified on 2022/10/21 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of urinary independence support for stroke patients by a urination care team
Acronym Effects of urinary independence support for stroke patients by a urination care team
Scientific Title Effects of urinary independence support for stroke patients by a urination care team
Scientific Title:Acronym Effects of urinary independence support for stroke patients by a urination care team
Region
Japan

Condition
Condition STROKE
Classification by specialty
Nursing
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 In 2022, our hospital began full-scale support for independent urination for stroke patients. Comparing 2021 and 2022, we consider and report the effect of providing urinary independence support for stroke patients.
Basic objectives2 Others
Basic objectives -Others In 2022, our hospital began full-scale support for independent urination for stroke patients. Comparing 2021 and 2022, we consider and report the effect of providing urinary independence support for stroke patients.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Supporting independent urination in stroke patients shortened the average duration of urinary catheter placement and reduced the incidence of febrile urinary tract infections. In addition, urinary independence and lower urinary tract function improved. It was suggested that support for independent micturition in stroke patients shortens the duration of indwelling bladder catheterization and reduces the incidence of febrile urinary tract infections. In addition, improvement of lower urinary tract functions such as incontinence and urinary retention may have a positive impact on the patient's QOL.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design n-of-1
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Target period: From September 2021 to the end of July 2022. Target patients: 35 stroke patients for whom the addition of independent urination support was calculated
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Stroke patients who calculated the addition of independent urination support
Key exclusion criteria none
Target sample size 35

Research contact person
Name of lead principal investigator
1st name Nobuhito
Middle name
Last name Yamashita
Organization National Hospital Organization Higashi-Hiroshima Medical Center
Division name nursing department
Zip code 739-0041
Address Hiroshimaken higashihirosimashi saijoutyoujike 513
TEL 082-423-2176
Email yamashita.nobuhito.kw@mail.hosp.go.jp

Public contact
Name of contact person
1st name Nobuhito
Middle name
Last name Yamashita
Organization National Hospital Organization Higashi-Hiroshima Medical Center
Division name nursing department
Zip code 739-0041
Address Hiroshimaken higashihirosimashi saijoutyoujike 513
TEL 082-423-2176
Homepage URL
Email yamashita.nobuhito.kw@mail.hosp.go.jp

Sponsor
Institute National Hospital Organization Higashi-Hiroshima Medical Center
Institute
Department

Funding Source
Organization National Hospital Organization Higashi-Hiroshima Medical Center
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Hospital Organization Higashi-Hiroshima Medical Center
Address Hiroshimaken higashihirosimashi saijoutyoujike 513
Tel 082-423-2176
Email yamashita.nobuhito.kw@mail.hosp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 35
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 10 Month 21 Day
Date of IRB
2022 Year 10 Month 21 Day
Anticipated trial start date
2022 Year 10 Month 21 Day
Last follow-up date
2022 Year 10 Month 21 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 10 Month 21 Day
Last modified on
2022 Year 10 Month 21 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056120